Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients.

Trial Profile

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Oct 2017

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Angina pectoris
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Aug 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 14 Nov 2011 Actual initiation date (October 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top